Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

241 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Transmission pathways and personal protective equipment requirement for mpox clade Ib lineage: nothing new on this front.
Decousser JW, Keita-Perse O, Aho Glele LS, Baron R, Carre Y, Cassier P, Chaize P, Coppry M, Dananche C, Florentin A, Fournier S, Racaud J, Rogues AM, Souyri V, Tamames C, Lavigne T, Parneix P, Romano-Bertrand S; Scientific Committee of the French Society for Hospital Hygiene. Decousser JW, et al. Among authors: cassier p. J Hosp Infect. 2024 Nov 13:S0195-6701(24)00371-2. doi: 10.1016/j.jhin.2024.10.018. Online ahead of print. J Hosp Infect. 2024. PMID: 39547538 No abstract available.
Identification of carbapenemase-producing Enterobacteriaceae reservoirs in wet hospital environments as a potential factor in patient acquisition: A cross-sectional study in a French university hospital in 2023.
Sleiman L, Dananché C, Gardes S, Fredenucci I, Duval C, Durieu I, Zoulim F, Vanhems P, Cassier P, Elias C. Sleiman L, et al. Among authors: cassier p. Infect Dis Now. 2024 Oct 25:104998. doi: 10.1016/j.idnow.2024.104998. Online ahead of print. Infect Dis Now. 2024. PMID: 39490809
Professional practice guidelines: Optimization of energy efficiency in controlled environment zones in operating theaters and interventional sectors.
Hafiani EM, Ortu S, Lopez D, Lallemant F, Dumaine V, Cassier P, Slim K, Pessaux P; with the Collectif d’écoresponsabilité en santé (CERES); Association française de chirurgie (AFC); Association pour la prévention et l’étude de la contamination (ASPEC); Société française d’hygiène hospitalière (SF2H); Société française d’anesthésie et de réanimation (SFAR); Société française de chirurgie orthopédique et traumatologique (SOFCOT). Hafiani EM, et al. Among authors: cassier p. J Visc Surg. 2024 Oct;161(5):344-352. doi: 10.1016/j.jviscsurg.2024.08.001. Epub 2024 Sep 27. J Visc Surg. 2024. PMID: 39341773
Identification of microenvironment features associated with primary resistance to anti-PD-1/PD-L1 + antiangiogenesis in gastric cancer through spatial transcriptomics and plasma proteomics.
Cousin S, Guégan JP, Shitara K, Palmieri LJ, Metges JP, Pernot S, Fukuoka S, Koyama S, Nishikawa H, Bellera CA, Adenis A, Gomez-Roca CA, Cassier PA, Hollebecque A, Cantarel C, Kind M, Soubeyran I, Vanhersecke L, Bessede A, Italiano A. Cousin S, et al. Among authors: cassier pa. Mol Cancer. 2024 Sep 13;23(1):197. doi: 10.1186/s12943-024-02092-x. Mol Cancer. 2024. PMID: 39272096 Free PMC article. Clinical Trial.
Durability of Response With Selpercatinib in Patients With RET-Activated Thyroid Cancer: Long-Term Safety and Efficacy From LIBRETTO-001.
Wirth LJ, Brose MS, Subbiah V, Worden F, Solomon B, Robinson B, Hadoux J, Tomasini P, Weiler D, Deschler-Baier B, Tan DSW, Maeda P, Lin Y, Singh R, Bayt T, Drilon A, Cassier PA. Wirth LJ, et al. Among authors: cassier pa. J Clin Oncol. 2024 Sep 20;42(27):3187-3195. doi: 10.1200/JCO.23.02503. Epub 2024 Aug 2. J Clin Oncol. 2024. PMID: 39094065 Free PMC article. Clinical Trial.
Plain language summary of the FOENIX-CCA2 study: futibatinib for people with advanced bile duct cancer.
Goyal L, Meric-Bernstam F, Hollebecque A, Valle JW, Morizane C, Karasic TB, Abrams TA, Furuse J, Kelley RK, Cassier PA, Klümpen HJ, Chang HM, Chen LT, Tabernero J, Oh DY, Mahipal A, Moehler M, Komatsu Y, Ahn DH, Epstein RS, Halim AB, Wacheck V, He Y, Liu M, Benhadji KA, Bridgewater JA; FOENIX-CCA2 Study Investigators. Goyal L, et al. Among authors: cassier pa. Future Oncol. 2024;20(36):2811-2822. doi: 10.1080/14796694.2024.2364504. Epub 2024 Jun 17. Future Oncol. 2024. PMID: 38884254 Clinical Trial.
Combining CD40 agonist mitazalimab with mFOLFIRINOX in previously untreated metastatic pancreatic ductal adenocarcinoma (OPTIMIZE-1): a single-arm, multicentre phase 1b/2 study.
Van Laethem JL, Borbath I, Prenen H, Geboes KP, Lambert A, Mitry E, Cassier PA, Blanc JF, Pilla L, Batlle JF, Garrote MR, Pazo-Cid RA, Gallego I, Smith KE, Ellmark P, Pico de Coaña Y, Ambarkhane SV, Macarulla T. Van Laethem JL, et al. Among authors: cassier pa. Lancet Oncol. 2024 Jul;25(7):853-864. doi: 10.1016/S1470-2045(24)00263-8. Epub 2024 Jun 1. Lancet Oncol. 2024. PMID: 38834087 Clinical Trial.
Qualitative evaluation of motives for acceptance or refusal of early palliative care in patients included in early-phase clinical trials in a French comprehensive cancer center: the PALPHA study.
Lochmann M, Girodet M, Despax J, Baudry V, Duranti J, Mastroianni B, Vanacker H, Vinceneux A, Brahmi M, Renard O, Verlingue L, Amini-Adle M, Swalduz A, Gautier J, Ducimetière F, Anota A, Cassier PA, Chvetzoff G, Christophe V. Lochmann M, et al. Among authors: cassier pa. Support Care Cancer. 2024 May 15;32(6):353. doi: 10.1007/s00520-024-08535-x. Support Care Cancer. 2024. PMID: 38748187
Lenvatinib plus pembrolizumab for patients with previously treated advanced ovarian cancer: Results from the phase 2 multicohort LEAP-005 study.
González-Martín A, Chung HC, Saada-Bouzid E, Yanez E, Senellart H, Cassier PA, Basu B, Corr BR, Girda E, Dutcus C, Okpara CE, Ghori R, Jin F, Groisberg R, Lwin Z. González-Martín A, et al. Among authors: cassier pa. Gynecol Oncol. 2024 Jul;186:182-190. doi: 10.1016/j.ygyno.2024.04.011. Epub 2024 May 7. Gynecol Oncol. 2024. PMID: 38718741 Free article. Clinical Trial.
NF-κB subunits RelA and c-Rel selectively control CD4+ T cell function in multiple sclerosis and cancer.
Lalle G, Lautraite R, Bouherrou K, Plaschka M, Pignata A, Voisin A, Twardowski J, Perrin-Niquet M, Stéphan P, Durget S, Tonon L, Ardin M, Degletagne C, Viari A, Belgarbi Dutron L, Davoust N, Postler TS, Zhao J, Caux C, Caramel J, Dalle S, Cassier PA, Klein U, Schmidt-Supprian M, Liblau R, Ghosh S, Grinberg-Bleyer Y. Lalle G, et al. Among authors: cassier pa. J Exp Med. 2024 Jun 3;221(6):e20231348. doi: 10.1084/jem.20231348. Epub 2024 Apr 2. J Exp Med. 2024. PMID: 38563819 Free PMC article.
241 results